153 related articles for article (PubMed ID: 30681615)
1. Screening of common genetic variants in the APOB gene related to familial hypercholesterolemia in a Saudi population: A case-control study.
Batais MA; Almigbal TH; Shaik NA; Alharbi FK; Alharbi KK; Ali Khan I
Medicine (Baltimore); 2019 Jan; 98(4):e14247. PubMed ID: 30681615
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.
Lye SH; Chahil JK; Bagali P; Alex L; Vadivelu J; Ahmad WA; Chan SP; Thong MK; Zain SM; Mohamed R
PLoS One; 2013; 8(4):e60729. PubMed ID: 23593297
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries.
Alhababi D; Zayed H
Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195
[TBL] [Abstract][Full Text] [Related]
4. Q192R polymorphism in the PON1 gene and familial hypercholesterolemia in a Saudi population.
Alharbi KK; Alnbaheen MS; Alharbi FK; Hasanato RM; Khan IA
Ann Saudi Med; 2017; 37(6):425-432. PubMed ID: 29229890
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
7. Familial defective apolipoprotein B-100: A review.
Andersen LH; Miserez AR; Ahmad Z; Andersen RL
J Clin Lipidol; 2016; 10(6):1297-1302. PubMed ID: 27919345
[TBL] [Abstract][Full Text] [Related]
8. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
[TBL] [Abstract][Full Text] [Related]
9. Genetic association between vitamin D receptor gene and Saudi patients confirmed with Familial Hypercholesterolemia.
Al-Nbaheen MS
Acta Biochim Pol; 2023 Nov; 70(4):829-834. PubMed ID: 38015195
[TBL] [Abstract][Full Text] [Related]
10. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
[TBL] [Abstract][Full Text] [Related]
11. The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia.
Hori M; Takahashi A; Son C; Ogura M; Harada-Shiba M
Lipids Health Dis; 2020 Apr; 19(1):62. PubMed ID: 32252761
[TBL] [Abstract][Full Text] [Related]
12. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.
Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in familial hypercholesterolemia and cascade screening in East Asians.
Chan ML; Cheung CL; Lee AC; Yeung CY; Siu CW; Leung JY; Pang HK; Tan KC
Mol Genet Genomic Med; 2019 Feb; 7(2):e00520. PubMed ID: 30592178
[TBL] [Abstract][Full Text] [Related]
16. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez AR; Martin FJ; Spirk D
Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
[TBL] [Abstract][Full Text] [Related]
17. Role of Apolipoprotein E gene polymorphism in the risk of familial hypercholesterolemia: a case-control study.
Almigbal TH; Batais MA; Hasanato RM; Alharbi FK; Khan IA; Alharbi KK
Acta Biochim Pol; 2018; 65(3):415-420. PubMed ID: 30235358
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
19. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
[TBL] [Abstract][Full Text] [Related]
20. Phenotype of definite familial hypercholesterolemia with negative genetic study in Argentina.
Corral P; Bañares V; Sáenz B; Zago V; Sarobe A; López G; Berg G; Schreier L
Arch Cardiol Mex; 2020; 90(2):130-136. PubMed ID: 32897268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
